VTRS·92556V106·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
VTRS (VIATRIS INC) is held by 263 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), DAVIS SELECTED ADVISERS ($1.1B), STATE STREET CORP ($705.7M). Net institutional sentiment: Mixed.
See how VTRS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer